baber/WOPTO huggingface dataset:
Patent NZ-299770-A (NZ)
Title: Combustion-powered fastener driving tool, fuel enters combustion chamber opposite a spark plug located at an end of the chamber
Inventor: ROBINSON JAMES W
IPC: B25C5/00
Filed: 1996-11-18
Abstract: A fuel system is provided for a combustion-powered tool (10) having a self-contained internal combustion power source (16) with a combustion chamber (62), and constructed and arranged for driving a drive blade (88) to impact a fastener (N) and drive it into a workpiece. The tool (10) includes a housing (12) having a main chamber (14) enclosing the power source (16) and having a first end (28) adjacent a nosepiece (76) wherein the fasteners (N) are positioned prior to driving, and a second end (34) opposite the first end (28) and adjacent the combustion chamber (62). A fuel cell chamber (18) is in communication with the main chamber (14) and has a first chamber end (28) corresponding to the first end (28) of the main chamber (14) and a second chamber end (40) corresponding to the second end (34) of the main chamber (14). A fuel metering valve (44) is disposed in the fuel cell chamber (18) at the first end (38) so that a fuel cell (50) having a fuel outlet end (52) operationally inserted into the fuel cell chamber (18) will engage the valve (44) so that fuel is dispensed into the valve in a location closer to the first chamber end (38) than to the second chamber end (40). <IMAGE>
Patent NZ-312672-A (NZ)
Title: Process for cleaning factory equipment with integrated prerinse where the cleaning solution is pumped directly into the equipment without a prior rinse
Inventor: LAUFENBERG ALFRED
IPC: B08B9/02
Filed: 1996-06-24
Abstract: PCT No. PCT/EP96/02752 Sec. 371 Date May 28, 1998 Sec. 102(e) Date May 28, 1998 PCT Filed Jun. 24, 1996 PCT Pub. No. WO97/02099 PCT Pub. Date Jan. 23, 1997A process for cleaning processing equipment for beverages or foods including the steps of (a) pumping a cleaning solution from its holding tank through the processing equipment in the absence of a pre-rinsing step, (b) collecting a first portion of the cleaning solution returning from the processing equipment into a recycling tank, (c) returning to the holding tank for the cleaning solution the main portion of the cleaning solution flowing through the processing equipment, (d) subjecting the first portion of the cleaning solution collected into the recycling tank to a separation process to provide a soil-rich concentrate and a low soil content regenerate, (e) transferring the regenerate to the holding tank for the cleaning solution, and (f) disposing of the soil-rich concentrate as waste.
Patent NZ-331591-A (NZ)
Title: Support structure for wheel-mounted vehicles comprises two part support arms pivotally mounted for side lifting
Inventor: HAMMAR BENGT-OLOF
IPC: B60S9/12
Filed: 1998-08-28
Abstract: A structure which is adapted to support a wheel mounted vehicle consists of at least two support parts which are relatively offset in the transverse direction of the vehicle and of which a first part is a support sleeve 7 supported by a pivot pin 6 connected to the vehicle chassis 2 and the second part 8 which is movably arranged in a bearing in the first support part ie support sleeve 7.  The support ie the two support parts 7 & 8 are pivotable between a parking position, in which they slope downwards to the side of the vehicle which is furthest away from pivot pin 6 of the support structure and at least one operative position, with an opposite inclination.  Support sleeve 7 has a longitudinal extent which in the parking position of the support corresponds to the width of the vehicle.  The ends of support sleeve 7 are bevelled 16, 17 to provide end faces that extend vertically when the support is in the parking position.
Patent NZ-334653-A (NZ)
Title: Thermostable nucleic acid polymerase with 3'-5' proofreading exonuclease ability from Thermococcus gorgonarius
Inventor: ANKENBAUER WALTRAUD
IPC: C12R1/19
Filed: 1997-10-01
Abstract: A purified thermostable enzyme is derived from the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90 % of its activity after incubation for two hours at 95oC in the presence of stabilising agents and possesses 3'-5' proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
Patent NZ-336397-A (NZ)
Title: Centrifuge apparatus comprising a piston displaceable in a cylindrical member and an optical blood cell detector
Inventor: JORGENSEN GLENN A
IPC: G01N33/48
Filed: 1998-01-08
Abstract: When the blood in the container 110 is centrifuged into fractions, plasma and cells, the piston rod 8 is drawn up so that firstly the plasma portion is transferred between top and bottom chambers of the container via narrow channels including a slit in a top extension 90 of the container.  As soon as blood cells are detected in the slit by optical detector 130 the controller 131 prevents further withdrawal of the piston rod 8 so that the blood cells are not transferred into the bottom chamber to interfere with the later recovery of fibrin monomer from the plasma fraction.
Patent NZ-337393-A (NZ)
Title: Polymeric amines with N-substituted 2,5-pyrrolediyl backbones and their use in curable resin and glued wood products
Inventor: BROEKHUIS ANTONIUS AUGUSTINUS
IPC: C07D207/33
Filed: 1998-03-23
Abstract: Polymeric amines that have N-substituted 2,5-pyrrolediyl groups incorporated in the backbone wherein the N-substituted 2,5-pyrrolediyl group may be represented by the above formula, wherein R independently represents a hydrogen atom or a hydrocarbyl group and wherein B represents the substituent containing at least one sterically hindered primary amino group.  Also claimed is the process for the preparation, curable resins and glued products comprising said polymeric amines.
Patent NZ-503129-A (NZ)
Title: Small particle liposome aerosols used for delivery of anti-cancer drugs
Inventor: KOSHKINA NADEZHDA
IPC: A61K38/21
Filed: 1998-09-23
Abstract: Lipid- or water-soluble anti-cancer drugs are incorporated into liposomes to enable delivery via a small particle aerosol from a jet nebulizer to the respiratory tract of an individual.  The ratio of anti-cancer drug to lipid in the liposome is in the range 1:1 to 1:200 wt:wt, preferably 1:10 to 1:50 wt: wt.  Examples of anti-cancer drugs that may be used include 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10,11-methylenedioxy-camptothecin and taxol or its derivatives.
Patent NZ-505767-A (NZ)
Title: Database management system with layered index arranged in blocks
Inventor: SHADMON MOSHE
IPC: G06F12/00
Filed: 1999-01-22
Abstract: A  database file management system for accessing  data records  is  being executed on data processing  system,  the data records are linked to a trie index that is arranged  in blocks  (402,  405,  406  and 407) and  being  stored  in  a storage  medium.  The trie index (A, B and I,  element  402) enables  accessing or updating the data records  by  key  or keys  and  being susceptible to an unbalanced  structure  of blocks.  There  is  provided  a method  for  constructing  a layered  index arranged in blocks, which includes the  steps of   providing   the   trie   index   and   constructing   a representative  index over the representative  keys  of  the trie  index. The layered index enables accessing or updating the  data  records  by  key or keys  and  it  constitutes  a balanced structure of blocks.
Patent NZ-508124-A (NZ)
Title: Concrete floors
Inventor: LAWLEY DEREK TRENT
IPC: E04F15/00
Filed: 2000-11-14
Abstract: A pair of metal angle sections (100, 101) are held together in abutting face to face relationship.  They are supported on bar chairs to function as a screed rail during pouring of a concrete floor.  Each angle section has a vertical limb (110, 110A), an upper horizontal portion (111, 112), and an aperture flange (114), to assist it in keying it into the concrete.  The flange (114) is stepped down below the plane of the horizontal portions (111, 112), and hence below the surface of the concrete.  During curing of the concrete, the abutting limbs (110, 110A) move apart to induce the formation of a crack.  This also provides a reinforced corner edge along the line of the crack.
Patent NZ-508464-A (NZ)
Title: Method for treatment of aqueous streams comprising biosolids using an anionic inorganic colloid and an organic polymer
Inventor: MOFFETT ROBERT HARVEY
IPC: C02F1/52
Filed: 1999-05-26
Abstract: A process for the clarification of aqueous process streams containing biosolids.  The process comprises contacting an aqueous stream comprising biosolids with: a) an anionic inorganic colloid; and b) an organic polymer having a number average molecular weight of greater than 1,000,000 and is selected from the group consisting of cationic polymers, amphoteric polymers, and mixtures thereof; whereby flocculated biosolids are produced.
Patent NZ-509126-A (NZ)
Title: Supporting device for dispensing volatile material
Inventor: KIMBALL JAMES F
IPC: A61L9/12
Filed: 1999-06-10
Abstract: A device (10) to support and dispenses volatile materials. The device is self-supporting and has a tent-like configuration. It can be hung from a bar. One of its side panels is connected to another by a tab and slot, or tab and pocket, arrangement above a base (16). The base connects the side panels (18,19). There is a reservoir (20) for dispensing the volatile material, which is mounted on one of the side panels, with a rear of the reservoir being positioned between two of the panels above the base.
Patent NZ-510201-A (NZ)
Title: Treatment of plants with salicylic acid and organic amines
Inventor: DEAN FRANK W
IPC: A01N37/40
Filed: 1999-07-20
Abstract: Disclosed are processes for improving plant resistance to disease without inhibiting plant growth. To achieve this, a plant is treated with an ortho-substituted benzoic acid, preferably salicylic acid, and a nitrogen-containing compound selected from the group consisting of the organic amines and compounds will metabolise to an organic amine. Preferred are the polyamines, tertiary amines, propylamines and organic compounds that will metabolise to produce a propylamine. Optionally, the plants are simultaneously treated with a chelated micronutrient metal preferably selected from the group consisting of the alkaline earth metals, the transition metals and boron. Finally, the plants are optionally treated with an ethylene-inducing compounded, preferably indole-3-butyric acid. Preferred method of application is to the foliage of the plant by way of a solution in a suitable carrier medium.
Patent NZ-510438-A (NZ)
Title: Soft intraocular lens folding device and storing case
Inventor: EGAWA YOSHIKAZU
IPC: A61F2/16
Filed: 2000-07-12
Abstract: A soft intraocular lens-folding device, comprising: a movable member; and a base member, wherein said movable member comprises an elastically bendable pair of legs, and a connecting portion for connecting this pair of legs, and at the tips of said pair of legs, there are disposed a lens- receiving portion for setting a soft intraocular lens astride both legs, and a wall portion for clamping said soft intraocular lens set in this lens-receiving portion, and said base member comprises a slide groove portion, which allows the tips of said pair of legs to penetrate and slide through, and which, in addition, is formed so as to narrow the gap between said pair of legs in accordance with the extent of movement therof.
Patent NZ-517522-A (NZ)
Title: Anti-proliferative medicaments that undergo preferential activation within the disease-affected cells and tissues
Inventor: KOZAK ALEXANDER
IPC: A61P25/28
Filed: 2000-09-13
Abstract: Described are prodrugs comprising anti-proliferative drugs covalently linked, via a bridging group, to a phospholipid moiety such that the active species is preferentially released, preferably by enzymatic cleavage, at the required site of action.  Also described are pharmaceutical compositions, the prodrugs and the uses thereof for the treatment of diseases and disorders related to inflammatory, to degenerative or atrophic conditions, and to uncontrolled cell growth.  The figure depicts a graph of animal survival during the course of an experiment wherein mice were transplanted by injection into the peritoneum with 11210 mouse leukaemia cells and then treated with vehicle only (squares), MTX (triangles) or molar equivalent dose of DP-MTX071 (circles) according to the regimen described in Example 11.
Patent NZ-517567-A (NZ)
Title: Single line spinnaker pole height control for sailboats and line stopper
Inventor: STEVENSON WILLIAM H
IPC: B63H9/10
Filed: 2002-03-04
Abstract: A  sailboat spinnaker pole control system  includes  a pole  control  line  supporting  an  outboard  end  of   the spinnaker  pole  and running from the pole  via  a  masthead sheave  62, a mast base sheave 64, through a car 50  movable along  on a vertical mast track 42 and to which the  inboard end  of  the spinnaker pole is attached, optionally via  the mast-fixed and car-mounted sheaves 74 and 76, the sheave  66 mounted  on  the  mast  above the car  track,  and  via  the turning  block near the base of the mast to a line  securing cleat.   A  slug  80 is secured at a fixed position  on  the line and the car includes a mechanism to secure the slug  80 of  the line.  In operation, when the slug 80 is secured  to the  car,  movement  of  the line  moves  the  car  and  the outboard end of the pole in the same direction.
Patent NZ-520604-A (NZ)
Title: Pigments having a viewing angle dependent shift of color, method for producing said pigments, use of said pigments in security applications, coating composition comprising said pigments and a detecting device
Inventor: ROZUMEK OLIVIER
IPC: B42D15/10
Filed: 2001-02-14
Abstract: Pigments comprise an interference structure having a light transmitting dielectric layer comprising at least one luminescent material and has a viewing angle dependent shift colour. The interference structure can have at least two thin film layers of different material. The luminescent material can be an organic or metal organic compound or trifluorides of rare earths or bismuth or mixtures thereof or complex fluorides of trivalent rare earth ions of bismuth and monovalent alkaline ions or divalent alkaline earth or transition ion. The rare earths are yttrium or lanthanodies and the transition ions are zinc. The pigments can be used in printing inks.
Patent NZ-523180-A (NZ)
Title: Consistency determining method and system, using parameter such as temperature
Inventor: JOHANSSON OLA M
IPC: D21D1/00
Filed: 2001-03-23
Abstract: A system (30) and method for determining stock consistency and for using consistency as a process variable to control some aspect of operation of a refiner used to refine stock. The system includes at least one sensor (70) from which some refiner characteristic is obtained that is used by a processor in determining consistency. The method uses the characteristic, such as temperature or pressure inside the refiner or in a refining zone of the refiner, along with at least one other refiner parameter in determining consistency. A controller uses the consistency determined in controlling some aspect of refiner operation. In one preferred controller, consistency is compared with a consistency setpoint and adjustments are made to try to converge consistency with the setpoint. The controller can be paused to accommodate other changes made to refiner operation and released when steady state refiner operation is achieved.
Patent NZ-527787-A (NZ)
Title: Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chemosensitizers
Inventor: KEEGAN KATHLEEN S
IPC: C07D403/12
Filed: 2002-03-01
Abstract: Disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment of checkpoint kinase 1 in a cell, wherein: X1 is O, S CH2, or N(R1), X2 is O, S or N(R1), Y is O or S, W is optionally substituted pyrazine, and Z is optionally substituted phenyl. Also disclosed are compounds of formula (II), for which the substituents are defined herein.
Patent NZ-528811-A (NZ)
Title: Apparatus for cleaning surfaces with automatic water supply and drain
Inventor: GERGEK FRANC
IPC: A47L5/38
Filed: 2002-03-12
Abstract: An apparatus for cleaning floor surfaces and the like includes a cleaning head and a vacuum head to apply water on the surface for a continuous cleaning and vacuum operation. A single water passage of the apparatus is adapted to be connected to an automatic central water supply and drain system to supply water to and withdraw used water from the apparatus alternately through the single water passage in a controlled manner. Fresh water and used water containers are provided for temporarily storing the fresh and used water respectively. A valve device is used to selectively direct the water flow from the single water passage to the fresh water container and water flow from the used water container to the single water passage. Dirt particles are separated from water and air, and are collected in a removable bin for periodic dumping. The apparatus of the invention assures a fully automatic and efficient wet cleaning and vacuuming operation.
Patent NZ-529164-A (NZ)
Title: Filler and a process for the production thereof
Inventor: SILENIUS PETRI
IPC: D21H17/67
Filed: 2002-04-24
Abstract: A filler comprising cellulose or lignocellulose fibrils on which light-scattering material particles have been deposited, and a process for the manufacture thereof is disclosed, wherein an alkyl derivative of cellulose, such as CMC, has been sorbed to the fibrils. Such a filler can be prepared from a source material containing cellulose or lignocellulose fibrils by first forming a fibril suspension, into which there are fed source materials forming an inorganic or organic salt that, when precipitating, forms a light-scattering pigment. These fillers have very good strength properties; in particular, good bond strength is achieved by means of it. By using these fillers the concentration of mineral pigment in paper can be increased and furthermore, the grammage of paper can be lowered without deteriorating the other important properties of the paper.
Patent NZ-533118-A (NZ)
Title: 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
Inventor: WISSNER ALLAN
IPC: A61P11/00
Filed: 2002-11-26
Abstract: Compounds of general formula I, methods for their manufacture and use as medicaments are disclosed. The compounds are effective for the treatment of neoplasms in mammals.
Patent NZ-533910-A (NZ)
Title: Valve status monitoring
Inventor: MASON SHANE MICHAEL
Filed: 2004-07-05
Abstract: A double seal valve 1 and methods for monitoring leakage past the seals are disclosed. The valve has two chambers 6, 8 joined by an intermediate passage 18 and is selectively configurable in three separate configurations. In the first configuration the intermediate passage is open, in a second 'closed' configuration the intermediate passage is closed by first 24 and second 26 seals seated at respective locations in the passage to create a leakage chamber 28 between the seals. In a third 'cleaning' configuration one of the two seals is unseated to connect one of the two valve chambers to the leakage chamber. A flow sensor 3 is connected to the leakage chamber to provide a signal indicative of a leakage flow from the leakage chamber.
Patent NZ-538255-A (NZ)
Title: Aqueous 2,6-diisopropylphenol pharmaceutical compositions
Inventor: ZHANG ZHONG
IPC: A61K47/18
Filed: 2003-07-29
Abstract: Disclosed herein is an aqueous formulation comprising, on a gram per ml (w/v) basis: 1-2 % 2,6-diisopropylphenoi; water and less than 15% excipients, said excipients consisting essentially of, on a gram per ml total formulation basis, about 2% to 8% polyethylene glycol (PEG), about 5% to about 9% of a block copolyrner, namely poloxamer 188, and, optionally, one or more pH modifiers, stabilizers, or tonicity modifiers, said formulation comprising an aqueous solution clear to the naked eye.
Patent NZ-540712-A (NZ)
Title: Steroidal sapogenin derivatives, their synthesis and their use in the treatment of cognitive dysfunction
Inventor: BARRACLOUGH PAUL
Filed: 2002-03-28
Abstract: Disclosed herein is a use of steroidal sapogenin derivative compounds of formula (II) (wherein the variables are as defined in the specification) including, all stereoisomers and racemic mixtures thereof, and their pharmaceutically acceptable salts, in the preparation of a medicament for the treatment or prevention of cognitive dysfunction in humans suffering therefrom or susceptible thereto. These medicaments are pharmaceutical compositions that are suitable for the treatment of cognitive dysfunction in the context of Parkinson's disease, myasthenia gravis, Lambert Eaton disease, Huntington's disease, multiple sclerosis, postural hypotension, chronic fatigue syndrome, asthma and susceptibility to heart failure.
Patent NZ-541269-A (NZ)
Title: Veterinary compositions for treating mastitis
Inventor: DORGAN RODERICK JOHN JEREMIAH
IPC: A61K9/00
Filed: 2003-12-08
Abstract: Disclosed is a veterinary composition for intra-mammary use in non-human animals comprising an antibacterial formulation and a separate seal formulation, wherein the antibacterial formulation is an oil-based formulation and the seal formulation comprises a gel base and a non-toxic heavy metal salt in the base in an amount of at least 30% by weight of the gel base. Also disclosed is a composition comprising an antibacterial formulation and a seal formulation formulated for administration to the teat canal of a non-human animal directly in one step, wherein the antibacterial formulation is an oil-based formulation and the seal formulation comprises a gel base and a non-toxic heavy metal salt in the base in an amount of at least 30% by weight of the gel base.
Patent NZ-546105-A (NZ)
Title: Method for preparing dried modified whey protein
Inventor: HAVEA PALATASA
Filed: 2006-03-23
Abstract: Disclosed is a method for preparing a dried modified whey protein concentrate or isolate comprising: (a) treating an aqueous whey protein concentrate or isolate of up to 30% (w/v) total solids, with (i) divalent metal hydroxide to change the pH to about 6.0 to about 8.5; or (ii) with divalent metal ion salt and adjusting the pH to change the pH to about 6.0 to about 8.5 and sufficient divalent metal ion salt is added to increase the divalent metal ion content of the whey protein concentrate either up to 3g/kg dry solids or at least 1.1-fold if already 3g/kg; and (b) heat treating the solution obtained to at least 70°C to denature the whey protein; and (c) drying the heat-treated whey protein concentrate or isolate wherein the whey protein concentrate or isolate has at least 65% (w/w) of total solids as whey protein.